Academy of Physicians
in Clinical Research

Academy of Physicians
in Clinical Research




News from SCRIP

APCR Members can get a free trial to SCRIP and a discount on a SCRIP subscription by contacting John Lezcano from SCRIP directly at the information below. 

John Lezcano
Corporate Account Manager

Pharma intelligence | informa
T: (212) 652-2678
M: (631) 807-4971
John.lezcano@informa.com
pharmaintelligence.informa.com

Bluebird Pushes For Zynteglo Pricing Of Five €315K Annual Installments

Fri, 06/14/2019 - 4:02am

CEO Nick Leschly talked to Scrip about the European payment strategy for the one-time gene therapy, which will cost €1.575m...

      Related Stories 

Novimmune Sells Gamifant And IO Assets To Sobi

Fri, 06/14/2019 - 12:59am

Swiss biotech Novimmune SA creates newco around Gamifant emapalumab and other immuno-oncology assets and then sells it to Sobi for...

      Related Stories 

Sobi Realigns Focus On Late-Stage Hematology & Immunology Assets

Fri, 06/14/2019 - 12:40am

Swedish specialty pharma and rare diseases company seeks to sustain recent rapid revenues growth with increased R&D focus and investments...

      Related Stories 

Dainippon Partnership Rejig Helps Healios Focus Resources

Thu, 06/13/2019 - 10:03pm

Big pharma partner takes on prime development responsibility for novel AMD cell therapy as Japanese venture concentrates resources on other...

      Related Stories 

Analysts Impressed As Novo Nordisk’s PIONEER 6 Trial Confirms Safety Profile Of Oral Semaglutide

Wed, 06/12/2019 - 8:39am

Oral semaglutide hit its main endpoint by demonstrating cardiovascular safety in people with type 2 diabetes and established cardiovascular disease...

      Related Stories 

USAID Reviewing India Financing Effort With Troubled DHFL

Wed, 06/12/2019 - 1:49am

The US Agency for International Development (USAID) is monitoring its Indian healthcare financing initiative with Dewan Housing Finance Corporation amid...

      Related Stories 

How Can Korea Grab Window Of Opportunity In AI Drug Development?

Tue, 06/11/2019 - 6:31pm

Participants at a recent policy forum in Seoul stressed the need to secure appropriate technology and expertise, unify government support...

      Related Stories 

Amgen's Oncology Strategy: Building A Pipeline Of Novel Paradigm-Changing Drugs

Tue, 06/11/2019 - 3:01pm

Amgen oncology development VP Greg Friberg talked to Scrip about the company's rapidly growing oncology portfolio. "This is our renaissance,"...

      Related Stories 

Roche's Polivy ADC Is Approved As Another New Option For R/R DLBCL

Tue, 06/11/2019 - 12:34pm

The first-in-class anti-CD79b antibody-drug conjugate received a swift accelerated approval by the US FDA based on the results of a...

      Related Stories 

Pages